Olle Nilsson
Hoofd Techniek/Wetenschap/O&O bij Fujirebio Diagnostics, Inc.
Profiel
Olle Nilsson is currently the Director at CYTO365 AB and the Chief Scientific Officer & Vice President at Fujirebio Diagnostics, Inc. He previously worked as the Chairman at AcouSort AB, Chief Scientific Officer & Vice President at Fujirebio Diagnostics AB, Principal at Phadia AB, and Principal at the University of Gothenburg.
Dr. Nilsson holds a graduate degree from the University of Uppsala and a doctorate degree from the University of Gothenburg.
Actieve functies van Olle Nilsson
Bedrijven | Functie | Begin |
---|---|---|
Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Hoofd Techniek/Wetenschap/O&O | 01-05-2006 |
CYTO365 AB
CYTO365 AB Medical SpecialtiesHealth Technology CYTO365 AB manufactures medical stopcock products for mixing of drugs. The company is based in Höganäs, Sweden. The Swedish company was founded by Micael Törnblom. Micael Törnblom has been the CEO since incorporation. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Olle Nilsson
Bedrijven | Functie | Einde |
---|---|---|
ACOUSORT AB | Voorzitter | - |
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Corporate Officer/Principal | - |
University of Gothenburg | Corporate Officer/Principal | - |
Fujirebio Diagnostics AB
Fujirebio Diagnostics AB Pharmaceuticals: MajorHealth Technology Fujirebio Diagnostics AB develops and manufactures immunological reagents. It focuses on the development of monoclonal antibodies which fight against biochemical markers of diseases. The firm distributes products to the international biotech and diagnostic industries. The company is headquartered in Gothenburg, Sweden. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Olle Nilsson
University of Uppsala | Graduate Degree |
University of Gothenburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ACOUSORT AB | Distribution Services |
Bedrijven in privébezit | 4 |
---|---|
Fujirebio Diagnostics AB
Fujirebio Diagnostics AB Pharmaceuticals: MajorHealth Technology Fujirebio Diagnostics AB develops and manufactures immunological reagents. It focuses on the development of monoclonal antibodies which fight against biochemical markers of diseases. The firm distributes products to the international biotech and diagnostic industries. The company is headquartered in Gothenburg, Sweden. | Health Technology |
Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Health Technology |
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Health Technology |
CYTO365 AB
CYTO365 AB Medical SpecialtiesHealth Technology CYTO365 AB manufactures medical stopcock products for mixing of drugs. The company is based in Höganäs, Sweden. The Swedish company was founded by Micael Törnblom. Micael Törnblom has been the CEO since incorporation. | Health Technology |